medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2005, Number 3

<< Back Next >>

Ann Hepatol 2005; 4 (3)

Hepatobiliary diseases in patients with human immunodeficiency virus (HIV) treated with non highly active anti-retroviral therapy: frequency and clinical manifestations

Lizardi-Cervera J, Soto RLE, Poo JL, Uribe M

Language: English
References: 21
Page: 188-191
PDF size: 46.57 Kb.


Text Extraction

Objective: To evaluate the frequency of hepatobiliary diseases and the clinical manifestations in patients with HIV treated with non highly active anti-retroviral therapy. Methods: Seven hundred clinical records of patients with HIV infection who entered the Instituto Nacional de Ciencias Médicas y de la Nutrición Salvador Zubirán from January 1987 to December 1996 were reviewed. All patients with alterations associated to hepatobiliary disease and/or liver function tests derangement throughout the clinical development of their disease were included. Demographic variables, date of diagnosis and clinical stage of the disease, as well as the presentation forms, diagnostic approach and image studies were analyzed. Results: One hundred and sixty-one patients (22.8%) with hepatobiliary manifestations were found. The average time between the HIV diagnosis and the presentation of hepatic manifestations was 2-12 years. The majority of patients 124/161 (77%) did not show clinical signs of liver damage. The diagnostic suspicion was established by the presence of alkaline phosphatase above normal in 29% and alkaline phosphatase plus aminotransferases above normal in 45%. Hepatomegaly and jaundice were present in 18% and 4% of the patients, respectively. The most frequent ultrasonographic diagnosis were hepatomegaly (40%) and steatosis (30%). Liver biopsies were performed in 85 (51%) of the patients. The main histologic diagnoses were granulomatous hepatitis (29%), steatosis plus granulomatous hepatitis (19.5%), and steatosis alone (14.6%). Microorganisms were isolated in 27.9% being the most frequent Mycobacterium tuberculosis (26.6%), Histoplasma capsulatum (20%), Cytomegalovirus (13.3%), and Mycobacterium avium intracellulare (11%). The HBsAg was positive in 21 of the 69 patients (30.4%). Conclusions: The clinical presentation was asymptomatic in most of cases and the main etiology could be explained by the presence of associated infections, granulomatoses and liver steatosis.


REFERENCES

  1. Manfredi R. HIV infection, antiretroviral therapy, and hepatic function. Emerging epidemiological, pathogenetic, and clinical issues, and their consequences on disease management. Aids 2003; 17: 2253-6. [PMID: 14523283].

  2. Poles MA, Lew EA, Dieterich DT. Diagnosis and treatment of hepatic disease in patients with HIV. Gastroenterol Clin North Am 1997; 26: 291-321. [PMID: 9187926].

  3. Mendez-Sanchez N, King-Martinez AC. Manifestaciones hepáticas de la infección por VIH. In: Conceptos actuales en hepatología, Mendez-Sanchez N, Uribe M, Editors. 2003, Masson Doyma Mexico: Mexico. p. 369-376.

  4. de Larranaga G, Peres S, Benetucci J. Relationship between hepatic enzymes and insulin resistance syndrome markers in HIV with lipodystrophy. Hepatology 2004; 40: 1475-6. [PMID: 15565605].

  5. Pol S, Lebray P, Vallet-Pichard A. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms. Clin Infect Dis 2004; 38 Suppl 2: S65-72. [PMID: 14986277].

  6. Kobessho H, Matsushita A, Takahashi K, Shimodaira M, Ishihara T, Oita T, Takahashi T. Hepatic encephalopathy in primary human immunodeficiency virus type 1 (HIV-1) infection. Intern Med 2002; 41: 1069-72. [PMID: 12487194].

  7. Uribe M, Passarelli L, Arista J, Schulz E, Paez O, Reyes E, Angeles A. [The liver in patients with acquired immunodeficiency syndrome. Diagnostic usefulness of the liver puncture biopsy]. Rev Invest Clin 1987; 39 Suppl: 35-40. [PMID: 3451326].

  8. Boyle BA. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2. AIDS Read 2001; 11: 387-90, 397. [PMID: 11570261].

  9. Boyle BA. Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part I. AIDS Read 2001; 11: 354-5, 359-61, 363. [PMID: 11494705].

  10. Ong KR, Iftikhar S, Glatt AE. Medical evaluation of the adult with HIV infection. Infect Dis Clin North Am 1994; 8: 289-301. [PMID: 8089461].

  11. Glatt AE. The ten commandments of caring for HIV-infected patients. Infect Dis Clin North Am 1994; 8: 275-8. [PMID: 8089460].

  12. Puoti M, Spinetti A, Ghezzi A, Donato F, Zaltron S, Putzolu V, Quiros-Roldan E, Zanini B, Casari S, Carosi G. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr 2000; 24: 211-7. [PMID: 10969344].

  13. Te HS. Cholestasis in HIV-infected patients. Clin Liver Dis 2004; 8: 213-28, viii-ix. [PMID: 15062202].

  14. Danesi G, Pianta P, Mastroianni A, Cicognani C, Cristoni L, Sama C. [Hepatic and pancreatic disease in patients with acquired immunodeficiency syndrome (AIDS)]. Minerva Med 1999; 90: 123-31. [PMID: 10518957].

  15. Boylston AW, Cook HT, Francis ND, Goldin RD. Biopsy pathology of acquired immune deficiency syndrome (AIDS). J Clin Pathol 1987; 40: 1-8. [PMID: 3029182].

  16. Karimi K, Wheat LJ, Connolly P, Cloud G, Hajjeh R, Wheat E, Alves K, Lacaz Cd Cda S, Keath E. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 2002; 186: 1655-60. [PMID: 12447743].

  17. Johnson PC, Khardori N, Najjar AF, Butt F, Mansell PW, Sarosi GA. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85: 152-8. [PMID: 3400691].

  18. Hawkins CC, Gold JW, Whimbey E, Kiehn TE, Brannon P, Cammarata R, Brown AE, Armstrong D. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 184-8. [PMID: 3729201].

  19. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6: 99-106. [PMID: 15807715].

  20. Yusuf TE, Baron TH. AIDS Cholangiopathy. Curr Treat Options Gastroenterol 2004; 7: 111-117. [PMID: 15010025].

  21. Blal CA, Passos SR, Horn C, Georg I, Bonecini-Almeida MG, Rolla VC, De Castro L. High prevalence of hepatitis B virus infection among tuberculosis patients with and without HIV in Rio de Janeiro, Brazil. Eur J Clin Microbiol Infect Dis 2005; 24: 41-3. [PMID: 15616838].




2020     |     www.medigraphic.com